Quality Assessment of New Liquid Biopsy Techniques

• Conditions: Cancer; neoplasm; 10027655

• Registration Number: NL-OMON49338
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. Metastatic cancer
2. Fit enough to deliver a maximum of 120 mL of peripheral blood, assessed
by treating physician
3. Written informed consent

Exclusion Criteria

None specified

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint of this study is to assess quality parameters (intra- and<br /><br>interlaboratory variation, time-to-processing influence, transport influence)<br /><br>of emerging liquid biopsy techniques.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>